1-4 of 4
David Vaughn
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Trial of Combretastatin A-4 Phosphate with Carboplatin

Joshua H. Bilenker, Keith T. Flaherty, Mark Rosen, Lisa Davis, Maryann Gallagher, James P. Stevenson, Weijing Sun, David Vaughn, Bruce Giantonio, Ross Zimmer, Mitchell Schnall, Peter J. O'Dwyer
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (4): 1527–1533.
https://doi.org/10.1158/1078-0432.CCR-04-1434
Published: 02 March 2005
View article titled, Phase I Trial of Combretastatin A-4 Phosphate with Carboplatin
Open the PDF for Phase I Trial of Combretastatin A-4 Phosphate with Carboplatin in another window
Journal Articles

Phase I and Pharmacokinetic Trial of the Novel Taxane BMS-184476 Administered as a 1-Hour Intravenous Infusion in Combination with Cisplatin Every 21 Days

Weijing Sun, James P. Stevenson, Maryann L. Gallagher, David Vaughn, Steven M. Hahn, Daniel G. Haller, Marvin Cohen, Justin Kopit, Gilles Gallant, Peter J. O’Dwyer
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (14): 5221–5227.
Published: 12 November 2003
View article titled, Phase I and Pharmacokinetic Trial of the Novel Taxane BMS-184476 Administered as a 1-Hour Intravenous Infusion in Combination with Cisplatin Every 21 Days
Open the PDF for Phase I and Pharmacokinetic Trial of the Novel Taxane BMS-184476 Administered as a 1-Hour Intravenous Infusion in Combination with Cisplatin Every 21 Days in another window
Journal Articles

Phase I Trial of the Cryptophycin Analogue LY355703 Administered as an Intravenous Infusion on a Day 1 and 8 Schedule Every 21 Days

James P. Stevenson, Weijing Sun, Maryann Gallagher, Robert Johnson, David Vaughn, Lynn Schuchter, Kenneth Algazy, Stephen Hahn, Nathan Enas, Diane Ellis, Donald Thornton, Peter J. O’Dwyer
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (8): 2524–2529.
Published: 01 August 2002
View article titled, Phase I Trial of the Cryptophycin Analogue LY355703 Administered as an Intravenous Infusion on a Day 1 and 8 Schedule Every 21 Days
Open the PDF for Phase I Trial of the Cryptophycin Analogue LY355703 Administered as an Intravenous Infusion on a Day 1 and 8 Schedule Every 21 Days in another window
Journal Articles

A Pilot Study of Interferon α-2a, Fluorouracil, and Leucovorin Given with Granulocyte-Macrophage Colony Stimulating Factor in Advanced Gastrointestinal Adenocarcinoma

Jeremy D. Shapiro, Nancy Harold, Chris Takimoto, J. Michael Hamilton, David Vaughn, Alice Chen, Seth M. Steinberg, David Liewehr, Carmen Allegra, Brian Monahan, Alex Lash, Frank Grollman, Donald Flemming, Katherine Behan, Patrick G. Johnston, Daniel Haller, Mary Quinn, Geraldine Morrison, Jean L. Grem
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (9): 2399–2408.
Published: 01 September 1999
View article titled, A Pilot Study of Interferon α-2a, Fluorouracil, and Leucovorin Given with Granulocyte-Macrophage Colony Stimulating Factor in Advanced Gastrointestinal Adenocarcinoma
Open the PDF for A Pilot Study of Interferon α-2a, Fluorouracil, and Leucovorin Given with Granulocyte-Macrophage Colony Stimulating Factor in Advanced Gastrointestinal Adenocarcinoma in another window